Acutus Medical to Present at the 41st Annual William Blair Growth Stock Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Acutus Medical, a leader in arrhythmia management, will participate in the 41st Annual William Blair Growth Stock Conference on June 3, 2021, at 12:20 p.m. Eastern Time. The event will be accessible through a live webcast on their investor relations website, with a replay available for 30 days post-presentation. Acutus Medical specializes in innovative solutions for the diagnosis and treatment of cardiac arrhythmias, enhancing the efficiency and effectiveness of electrophysiology practices.
Details
News Market Reaction – AFIB
The recorded move for AFIB in the trading session of this news was +0.07%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will participate at the 41st Annual William Blair Growth Stock Conference on Thursday, June 3, 2021 at 12:20 p.m. Eastern Time.
A live webcast of the presentation may be accessed by visiting ir.acutusmedical.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation.
About Acutus Medical
Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products that provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.
Investor Contact:
Caroline Corner
Westwicke ICR
D: 415-202-5678
caroline.corner@westwicke.com
Holly Windler
M: 619-929-1275
media@acutusmedical.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.